SCHEMBL9708549

SCHEMBL9708549

CCn1c(=O)n(C)c(=O)c2c1nc(C1CCCCC1)n2Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1

nearest known ligand 0.45

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.45
PDE5A O76074 4/20 0.42
AGTR1 P30556 3/20 0.41
AGTR2 P50052 3/20 0.41
MAPK1 P28482 2/20 0.41
TP53 P04637 2/20 0.41
HSD17B10 Q99714 2/20 0.41
TSHR P16473 1/20 0.41
POLB P06746 1/20 0.40
BLM P54132 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
CTDSP1 Q9GZU7 1/20 0.40
ADORA3 P0DMS8 1/20 0.38
ADORA2A P29274 1/20 0.38
ADORA2B P29275 1/20 0.38
LMNA P02545 1/20 0.38
HPGD P15428 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9708269 0.95 ADORA2A (0.46) KMT2AAGTR1AGTR2MAPK1TP53
SCHEMBL9708135 0.94 KMT2A (0.43) KMT2APDE5AAGTR1AGTR2MAPK1
SCHEMBL9707789 0.94 PDE5A (0.49) KMT2APDE5AAGTR1AGTR2ADORA3
SCHEMBL9708520 0.93 TSHR (0.48) KMT2AAGTR1AGTR2MAPK1TP53
SCHEMBL9708170 0.92 ADORA3 (0.48) KMT2APDE5AAGTR1AGTR2ADORA3
SCHEMBL9707534 0.92 KMT2A (0.44) KMT2APDE5AAGTR1AGTR2MAPK1
SCHEMBL9707524 0.92 KMT2A (0.44) KMT2APDE5AAGTR1AGTR2MAPK1
SCHEMBL9708354 0.92 KMT2A (0.47) KMT2AAGTR1AGTR2MAPK1TP53
SCHEMBL9708008 0.92 ADORA3 (0.46) KMT2APDE5AAGTR1AGTR2ADORA3
SCHEMBL9708551 0.91 KMT2A (0.43) KMT2AAGTR1AGTR2MAPK1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1992007852-A1 BIPHENYLALKYL XANTHINE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1992-05-14 WO disclosed